Home » Topics » Briefs » Other news to note

Other news to note
RSS

VX-740: new lead antiinflammatory compound from Vertex/HMR

July 7, 1997

Faulding forms Faulding Soltec DDS

July 7, 1997

Company profile: The Medicines Company

July 7, 1997

Japanese companies focus on overseas development

July 7, 1997

Triangle Pharmaceuticals to acquire Avid Corporation

July 4, 1997

Name change for Sheffield approved by shareholders

July 4, 1997

Guilford presents prototype presynaptic glutamate blocker

July 4, 1997

PARS inhibitors under development by Guilford for stroke

July 4, 1997

Icos PDE V inhibitor in phase I trials

July 4, 1997

Prostaglandins in early development at Allergan for glaucoma

July 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.